Guidance for providers on the treatment and management of cutaneous lupus erythematosus

B F Chong¹

Affiliations

Comment

B F Chong. Br J Dermatol. 2021 Dec.

. 2021 Dec;185(6):1084.

doi: 10.1111/bjd.20746. Epub 2021 Sep 30.

B F Chong¹

¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

No abstract available

Comment on

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.
O'Kane D, McCourt C, Meggitt S, D'Cruz DP, Orteu CH, Benton E, Wahie S, Utton S, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. O'Kane D, et al. Br J Dermatol. 2021 Dec;185(6):1112-1123. doi: 10.1111/bjd.20597. Epub 2021 Oct 19. Br J Dermatol. 2021. PMID: 34170012 No abstract available.

1. Elman SA, Joyce C, Braudis K et al. Creation and validation of classification criteria for discoid lupus erythematosus. JAMA Dermatol 2020; 156:901-6.
1. American Academy of Dermatology. Evidence-based clinical practice guidelines. https://server.aad.org/Forms/Policies/Uploads/AR/AR%20-%20Evidence-Based... (last accessed 17 August 2021).
1. Brouwers MC, Kho ME, Browman GP et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182:E839-42.
1. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.
1. O’Kane D, McCourt C, Meggitt S et al. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021. Br J Dermatol 2021; 185:1112-23.